| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d068051ccd727c88f8c8e74fec8d74c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2016-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd17d82ed60608bd34267e6a82b72899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96f822daccff73cb36de63637e98cf1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1358ffedef1301356847e498926bb627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2943bee91c15d649537b099fcb60225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10c0ee336bb9d342224a13691f39ef75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b7b14dda4e2191a9de4275d5b933ddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eafb946194de4e1c6c0999b412d95f7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79e14d1ffce7a69a5b3c796e6f4487c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66425a910cbc41e030a9ba9d50df2c47 |
| publicationDate |
2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106566812-A |
| titleOfInvention |
Hybridoma cell strain XA272-917, antibody and application of antibody |
| abstract |
The invention relates to a hybridoma cell strain XA272-917, an antibody and an application of the antibody. The involved hybridoma cell strain is characterized by having a collection number of CCTCC NO:C2016113. The involved antibody is an antibody secreted by the hybridoma cell strain. The involved application is an application of the antibody to the detection of human CTRP9A and an application of the antibody to the preparation of a human CTRP9A detection kit. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112444627-A |
| priorityDate |
2016-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |